4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-007395
Chairman and CEO bought 13,250 shares at an average $1.42 ($18,760)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-02-03 | Purchase | +6,250 | $1.40 | $8,750 | 11,148,406 | D |
| Niihara Yutaka Chairman and CEO | 2022-02-04 | Purchase | +7,000 | $1.43 | $10,010 | 11,155,406 | D |
| Open-market purchases · 13,250 sh · avg $1.42 · $18,760 | |||||||
Loading xslF345X03/doc4.xml…